Expert Opinion on Therapeutic Targets This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

What do we know about the renin angiotensin system and inflammatory bowel disease?
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 23, 2022 Category: Drugs & Pharmacology Authors: Sheng Wei Lo Jonathan P. Segal John S. Lubel Mayur Garg Source Type: research

Combining inhibition of immune checkpoints and PARP: rationale and perspectives in cancer treatment
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 22, 2022 Category: Drugs & Pharmacology Authors: Martina Catalano Luigi Francesco Iannone Federica Cosso Daniele Generali Enrico Mini Giandomenico Roviello Source Type: research

Secretory autophagy: a turn key for understanding AMD pathology and developing new therapeutic targets?
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 19, 2022 Category: Drugs & Pharmacology Authors: Janusz Blasiak Kai Kaarniranta Source Type: research

The genetic background of Parkinson ’s disease and novel therapeutic targets
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 16, 2022 Category: Drugs & Pharmacology Authors: Andr ás Salamon D énes Zádori L ászló Szpisjak P éter Klivényi L ászló Vécsei Source Type: research

Serotonin and valvular heart disease
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 15, 2022 Category: Drugs & Pharmacology Authors: Helge Waldum Rune Wiseth Alexander Wahba Source Type: research

High levels of HDAC expression correlate with microglial aging
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 15, 2022 Category: Drugs & Pharmacology Authors: Jaione Auzmendi-Iriarte Leire Moreno-Cugnon Ander Saenz-Anto ñanzas Daniela Grassi Marian M de Pancorbo Maria-Angeles Arevalo Ian C Wood Ander Matheu Source Type: research

Dyskinesia and Parkinson ’s disease: animal model, drug targets, and agents in preclinical testing
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - December 13, 2022 Category: Drugs & Pharmacology Authors: Valentina Cesaroni Fabio Blandini Silvia Cerri Source Type: research

Correction
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 25, 2022 Category: Drugs & Pharmacology Source Type: research

Preclinical target validation for non-addictive therapeutics development for pain
Volume 26, Issue 9, September 2022, Page 811-822 . (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 25, 2022 Category: Drugs & Pharmacology Authors: Richard Hargreaves Karen Akinsanya Seena K. Ajit Neel T. Dhruv Jamie Driscoll Peter Farina Narender Gavva Marie Gill Andrea Houghton Smriti Iyengar Carrie Jones Annemieke Kavelaars Ajamete Kaykas Walter J. Koroshetz Pascal Laeng Jennifer M. Laird Donald C Source Type: research

Telomerase: a good target in hepatocellular carcinoma? An overview of relevant preclinical data
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 18, 2022 Category: Drugs & Pharmacology Authors: Maria Lina Tornesello Anna Lucia Tornesello Noemy Starita Andrea Cerasuolo Francesco Izzo Luigi Buonaguro Franco Maria Buonaguro Source Type: research

MT1-MMP – A potential drug target for the management of the obesity
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 17, 2022 Category: Drugs & Pharmacology Authors: Pallavi Asthana Xuanming Guo Hoi Leong Xavier Wong Source Type: research

Identifying molecular mechanisms of acute to chronic pain transition and potential drug targets
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - November 12, 2022 Category: Drugs & Pharmacology Authors: Kannan Aravagiri Adam Ali Hank C Wang Kenneth D Candido Nebojsa Nick Knezevic Source Type: research

The adenosine A2A receptor is a therapeutic target in neurological, heart and oncogenic diseases
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - October 27, 2022 Category: Drugs & Pharmacology Authors: Rafael Franco Alejandro Lillo Gemma Navarro Irene Reyes-Resina Source Type: research

The molecular mechanisms and targeting strategies of transcription factors in cholangiocarcinoma
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - October 20, 2022 Category: Drugs & Pharmacology Authors: Jiao Wang Fujing Ge Tao Yuan Meijia Qian Fangjie Yan Bo Yang Qiaojun He Hong Zhu Source Type: research

Emerging pharmacologic interventions for pre-eclampsia treatment
. (Source: Expert Opinion on Therapeutic Targets)
Source: Expert Opinion on Therapeutic Targets - October 20, 2022 Category: Drugs & Pharmacology Authors: Xiao Zhang Yue Chen Dongli Sun Xiaojun Zhu Xia Ying Yao Yao Weidong Fei Caihong Zheng Source Type: research